🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Frequency variation and dose modification of benznidazole administration for the treatment of Trypanosoma cruzi infection in mice, dogs and non-human primates

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.01.526739Source: DataRank Database

Frequency variation and dose modification of benznidazole administration for the treatment of Trypanosoma cruzi infection in mice, dogs and non-human primates is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: greenTopics (14)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Brooke E. White ORCID,Gregory K. Wilkerson ORCID,Carolyn L. Hodo ORCID,Lisa D. Auckland ORCID,Wei Wang ORCID

Live enrichment

PubMed:21097893

National Institutes of Health

Grant: 5R01AI151148-05

Trypanosoma cruzi dormancy and its implications for therapeutic treatment

National Institutes of Health

Grant: 5R21AI142469-02

A more effective drug treatment regimen for Trypanosoma cruzi infection

National Institutes of Health

Grant: 5R01AI125738-02

Multiplex treatment outcomes test for Chagas disease

National Institutes of Health

Grant: 1UL1TR003163-01A1

UT Southwestern Center for Translational Medicine

greenLicense: cc-by-nc-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2023/02/02/2023.02.01.526739.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.02.01.526739

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC9915573/pdf/nihpp-2023.02.01.526739v1.pdf

https://doi.org/10.1101/2023.02.01.526739

https://doi.org/10.1128/aac.00132-23

Fields of Study

03 medical and health sciences0302 clinical medicine

Keywords

PrimatesMammalsTrypanosoma cruziTrypanocidal AgentsArticleMiceDogsClinical ProtocolsNitroimidazolesHumansAnimalsChagas Disease

Sustainable Development Goals

SDG 3: 3. Good health